ArticleAntiviral research2023

Development of highly effective LCB1-based lipopeptides targeting the spike receptor-binding motif of SARS-CoV-2.

Yuanmei Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.